Rapid prototyping and fabrication of elastomeric molds for sterile culture of engineered tissues allow for the development of tissue geometries that can be tailored to different in vitro applications and customized as implantable scaffolds for regenerative medicine. Commercially available molds offer minimal capabilities for adaptation to unique conditions or applications versus those for which they are specifically designed. Here we describe a replica molding method for the design and fabrication of poly(dimethylsiloxane) (PDMS) molds from laser-etched acrylic negative masters with ∼0.2 mm resolution. Examples of the variety of mold shapes, sizes, and patterns obtained from laser-etched designs are provided. We use the patterned PDMS molds for producing and culturing engineered cardiac tissues with cardiomyocytes derived from human-induced pluripotent stem cells. We demonstrate that tight control over tissue morphology and anisotropy results in modulation of cell alignment and tissue-level conduction properties, including the appearance and elimination of reentrant arrhythmias, or circular electrical activation patterns. Techniques for handling engineered cardiac tissues during implantation in vivo in a rat model of myocardial infarction have been developed and are presented herein to facilitate development and adoption of surgical techniques for use with hydrogel-based engineered tissues. In summary, the method presented herein for engineered tissue mold generation is straightforward and low cost, enabling rapid design iteration and adaptation to a variety of applications in tissue engineering. Furthermore, the burden of equipment and expertise is low, allowing the technique to be accessible to all.
Get full access to this article
View all access options for this article.
References
1.
NevesL.S., RodriguesM.T., ReisR.L., and GomesM.E.Current approaches and future perspectives on strategies for the development of personalized tissue engineering therapies. Expert Rev Precis Med Drug Dev, 1, 93, 2016.
2.
HoffmanA.S.Hydrogels for biomedical applications. Adv Drug Deliv Rev, 54, 3, 2002.
3.
McCainM.L., AgarwalA., NesmithH.W., NesmithA.P., and ParkerK.K.Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues. Biomaterials, 35, 5462, 2014.
4.
LeeK.Y., and MooneyD.J.Hydrogels for tissue engineering. Chem Rev, 101, 1869, 2001.
5.
KloxinA.M., KloxinC.J., BowmanC.N., and AnsethK.S.Mechanical properties of cellularly responsive hydrogels and their experimental determination. Adv Mater, 22, 3484, 2010.
6.
AubinH., NicholJ.W., HutsonC.B., BaeH., SieminskiA.L., CropekD.M., AkhyariP., and KhademhosseiniA.Directed 3D cell alignment and elongation in microengineered hydrogels. Biomaterials, 31, 6941, 2010.
7.
HuJ.J., ChenG.W., LiuY.C., and HsuS.S.Influence of specimen geometry on the estimation of the planar biaxial mechanical properties of cruciform specimens. Exp Mech, 54, 615, 2014.
8.
GraysonW.L., FröhlichM., YeagerK., BhumiratanaS., ChanM.E., CannizzaroC., WanL.Q., LiuX.S., GuoX.E., and Vunjak-NovakovicG.Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci U S A, 107, 3299, 2010.
9.
MoroniL., CurtiM., WeltiM., KoromS., WederW., de WijnJ.R., and van BlitterswijkC.A.Anatomical 3D fiber-deposited scaffolds for tissue engineering: designing a neotrachea. Tissue Eng, 13, 2483, 2007.
BertassoniL.E., CecconiM., ManoharanV., NikkhahM., HjortnaesJ., CristinoA.L., BarabaschiG., DemarchiD., DokmeciM.R., YangY., and KhademhosseiniA.Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab Chip, 14, 2202, 2014.
12.
BhumiratanaS., BernhardJ.C., AlfiD.M., YeagerK., EtonR.E., BovaJ., ShahF., GimbleJ.M., LopezM.J., EisigS.B., and Vunjak-NovakovicG.Tissue-engineered autologous grafts for facial bone reconstruction. Sci Transl Med, 8, 343ra83, 2016.
13.
TurnerW.S., WangX., JohnsonS., MedberryC., MendezJ., BadylakS.F., McCordM.G., and McCloskeyK.E.Cardiac tissue development for delivery of embryonic stem cell-derived endothelial and cardiac cells in natural matrices. J Biomed Mater Res B Appl Biomater, 100, 2060, 2012.
14.
ZhangH., and ChiaoM.Anti-fouling coatings of poly(dimethylsiloxane) devices for biological and biomedical applications. J Med Biol Eng, 35, 143, 2015.
15.
GerbinK.A., YangX., MurryC.E., and CoulombeK.L.K.Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts. PLoS One, 10, e0131446, 2015.
16.
BianW., and BursacN.Engineered skeletal muscle tissue networks with controllable architecture. Biomaterials, 30, 1401, 2009.
17.
GilchristC.L., RuchD.S., LittleD., and GuilakF.Micro-scale and meso-scale architectural cues cooperate and compete to direct aligned tissue formation. Biomaterials, 35, 10015, 2014.
18.
LiauB., ChristoforouN., LeongK.W., and BursacN.Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials, 32, 9180, 2011.
19.
HelmP., BegM., MillerM.I., and WinslowR.L.Measuring and mapping cardiac fiber and laminar architecture using diffusion tensor MR imaging. Ann N Y Acad Sci, 1047, 296, 2005.
20.
KadotaS., MinamiI., MoroneN., HeuserJ.E., AgladzeK., and NakatsujiN.Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets. Eur Heart J, 34, 1147, 2013.
21.
MunarinF., and CoulombeK.L.K.A novel 3-dimensional approach for cardiac regeneration. Conf Proc IEEE Eng Med Biol Soc, 2015, 1741, 2015.
22.
WangH., SvoronosA.A., BoudouT., SakarM.S., SchellJ.Y., MorganJ.R., et al.Necking and failure of constrained 3D microtissues induced by cellular tension. Proc Natl Acad Sci U S A, 110, 20923, 2013.
23.
FengZ., WagatsumaY., KikuchiM., KosawadaT., NakamuraT., SatoD., et al.The mechanisms of fibroblast-mediated compaction of collagen gels and the mechanical niche around individual fibroblasts. Biomaterials, 35, 8078, 2014.
24.
BianW., BadieN., HimelH.D., and BursacN.Robust T-tubulation and maturation of cardiomyocytes using tissue-engineered epicardial mimetics. Biomaterials, 35, 3819, 2014.
25.
BianW., JackmanC.P., and BursacN.Controlling the structural and functional anisotropy of engineered cardiac tissues. Biofabrication, 6, 024109, 2014.
26.
GrosbergA., and GharibM.A dynamic double helical band as a model for cardiac pumping. Bioinspir Biomim, 4, 026003, 2009.
27.
FentonF.H., CherryE.M., HastingsH.M., and EvansS.J.Multiple mechanisms of spiral wave breakup in a model of cardiac electrical activity. Chaos, 12, 852, 2002.
28.
UrsellP.C., GardnerP.I., AlbalaA., FenoglioJ.J.Jr., and WitA.L.Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing. Circ Res, 56, 436, 1985.
29.
HooksD.A., TomlinsonK.A., MarsdenS.G., LeGriceI.J., SmaillB.H., PullanA.J., and HunterP.J.Cardiac microstructure: implications for electrical propagation and defibrillation in the heart. Circ Res, 91, 331, 2002.
30.
JanseM.J.Electrophysiology of arrhythmias. Arch Mal Coeur Vaiss, 92 Spec No 1, 9, 1999.
31.
JanseM.J.Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res, 61, 208, 2004.
32.
ZipesD.P., HegerJ.J., and PrystowskyE.N.Pathophysiology of arrhythmias: clinical electrophysiology. Am Heart J, 106, 812, 1983.
33.
ElsonJ., and MasonJ.W.General concepts and mechanisms of ventricular tachycardia. Cardiol Clin, 4, 459, 1986.
34.
StevensonW.G.Mechanisms and management of arrhythmias in heart failure. Curr Opin Cardiol, 10, 274, 1995.
35.
DucceschiV., Di MiccoG., SarubbiB., RussoB., SantangeloL., and IaconoA.Ionic mechanisms of ischemia-related ventricular arrhythmias. Clin Cardiol, 19, 325, 1996.
NoujaimS.F., AuerbachD.S., and JalifeJ.Ventricular fibrillation: dynamics and ion channel determinants. Circ J, 71Suppl A, A1, 2007.
38.
ZimmermannW.-H., MelnychenkoI., and EschenhagenT.Engineered heart tissue for regeneration of diseased hearts. Biomaterials, 25, 1639, 2004.
39.
WendelJ.S., YeL., ZhangP., TranquilloR.T., and ZhangJ.J.Functional consequences of a tissue-engineered myocardial patch for cardiac repair in a rat infarct model. Tissue Eng Part A, 20, 1325, 2014.
40.
WeinbergerF., BreckwoldtK., PechaS., KellyA., GeertzB., StarbattyJ., YorganT., ChengK.-H., LessmannK., StolenT., Scherrer-CrosbieM., SmithG., ReichenspurnerH., HansenA., and EschenhagenT.Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells. Sci Transl Med, 8, 363ra148, 2016.
41.
ToepkeM.W., and BeebeD.J.PDMS absorption of small molecules and consequences in microfluidic applications. Lab Chip, 6, 1484, 2006.
42.
SuX., YoungE.W.K., UnderkoflerH.A.S., KampT.J., JanuaryC.T., and BeebeD.J.Microfluidic cell culture and its application in high throughput drug screening: cardiotoxicity assay for hERG channels. J Biomol Screen, 16, 101, 2011.
43.
RobertsM.A., TranD., CoulombeK.L.K., RazumovaM., RegnierM., MurryC.E., and ZhengY.Stromal cells in dense collagen promote cardiomyocyte and microvascular patterning in engineered human heart tissue. Tissue Eng Part A, 22, 633, 2016.
BlakelyA.M., ManningK.L., TripathiA., and MorganJ.R.Bio-pick, place, and perfuse: a new instrument for three-dimensional tissue engineering. Tissue Eng Part C Methods, 21, 737, 2015.
46.
MandalB.B., GrinbergA., Seok GilE., PanilaitisB., and KaplanD.L.High-strength silk protein scaffolds for bone repair. Proc Natl Acad Sci U S A, 109, 7699, 2012.
47.
ChangN.J., YehM.L., and JhungY.R.Fabricating PLGA sponge scaffold integrated with gelatin/hyaluronic acid for engineering cartilage. IEEE 35th Annual Northeast Bioengineering Conference, 2009, 1, 2009.
48.
WangX., YouC., HuX., ZhengY., LiQ., FengZ., SunH., GaoC., and HanC.The roles of knitted mesh-reinforced collagen-chitosan hybrid scaffold in the one-step repair of full-thickness skin defects in rats. Acta Biomater, 9, 7822, 2013.
49.
BurridgeP.W., MatsaE., ShuklaP., LinZ.C., ChurkoJ.M., EbertA.D., LanF., DieckeS., HuberB., MordwinkinN.M., PlewsJ.R., AbilezO.J., CuiB., GoldJ.D., and WuJ.C.Chemically defined and small molecule-based generation of human cardiomyocytes. Nat Methods, 11, 855, 2014.
50.
LianX., HsiaoC., WilsonG., ZhuK., HazeltineL.B., AzarinS.M., RavalK.K., ZhangJ., KampT.J., and PalecekS.P.Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A, 109, E1848, 2012.
51.
DesrochesB.R., ZhangP., ChoiB.R., KingM.E., MaldonadoA.E., LiW., RagoA., LiuG., NathN., HartmannK.M., YangB., KorenG., MorganJ.R., and MendeU.Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells. Am J Physiol Heart Circ Physiol, 302, H2031, 2012.
52.
ChoiB.R., JangW., and SalamaG.Spatially discordant voltage alternans cause wavebreaks in ventricular fibrillation. Heart Rhythm, 4, 1057, 2007.
53.
ZivO., MoralesE., SongY.K., PengX., OdeningK.E., BuxtonA.E., KarmaA., KorenG., and ChoiB.R.Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome. J Physiol, 587, 4661, 2009.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
